Crestwood Advisors Group LLC lessened its position in Danaher Corporation (NYSE:DHR – Free Report) by 4.9% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 301,000 shares of the conglomerate’s stock after selling 15,651 shares during the period. Danaher comprises about 1.1% of Crestwood Advisors Group LLC’s investment portfolio, making the stock its 24th biggest holding. Crestwood Advisors Group LLC’s holdings in Danaher were worth $68,905,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Elevated Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter worth approximately $26,000. JPL Wealth Management LLC bought a new position in shares of Danaher in the third quarter worth approximately $25,000. WFA of San Diego LLC purchased a new position in shares of Danaher during the second quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd purchased a new position in shares of Danaher during the third quarter valued at approximately $27,000. Finally, Financial Life Planners purchased a new position in shares of Danaher during the third quarter valued at approximately $32,000. Institutional investors own 79.05% of the company’s stock.
Insider Buying and Selling
In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 10.80% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Research Report on Danaher
Danaher Stock Up 0.4%
Shares of DHR stock opened at $175.55 on Friday. Danaher Corporation has a 12 month low of $172.06 and a 12 month high of $242.80. The stock has a market cap of $124.25 billion, a P/E ratio of 33.95, a P/E/G ratio of 2.34 and a beta of 0.81. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The company has a 50 day simple moving average of $191.25 and a two-hundred day simple moving average of $212.54.
Danaher (NYSE:DHR – Get Free Report) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the prior year, the company earned $1.88 earnings per share. The firm’s revenue was up 3.7% on a year-over-year basis. On average, research analysts expect that Danaher Corporation will post 8.43 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
